Increased Risk of Glaucoma in Patients with Sjögren’s Syndrome: A Nationwide Population-Based Cohort Study

References

• Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983–1989. doi:10.1136/annrheumdis-2014-205375.
   PubMed Web of Science ®Google Scholar
• Pillemer SR, Matteson EL, Jacobsson LT, et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001;76(6):593–599. doi:10.4065/76.6.593.
   PubMed Web of Science ®Google Scholar
• See LC, Kuo CF, Chou IJ, Chiou MJ, Yu KH. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum. 2013;43(3):381–386. doi:10.1016/j.semarthrit.2013.06.001.
   PubMed Web of Science ®Google Scholar
• Maldini C, Seror R, Fain O, et al. Epidemiology of primary Sjögren’s syndrome in a French multiracial/multiethnic area [published correction appears in Arthritis Care Res (Hoboken). 2014 May;66(5): 794]. Arthritis Care Res (Hoboken). 2014;66(3):454–463. doi:10.1002/acr.22115.
   PubMed Web of Science ®Google Scholar
• Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren’s syndrome: a community-based study of prevalence and impact. Br J Rheumatol. 1998;37(10):1069–1076. doi:10.1093/rheumatology/37.10.1069.
   PubMedGoogle Scholar
• Locht H, Pelck R, Manthorpe R. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n=321) cohort of patients with primary Sjögren’s syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria. Autoimmun Rev. 2005;4(5):276–281. doi:10.1016/j.autrev.2004.12.002.
   PubMed Web of Science ®Google Scholar
• Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363(9422):1711–1720. doi:10.1016/S0140-6736(04)16257-0.
   PubMed Web of Science ®Google Scholar
• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224.
   PubMed Web of Science ®Google Scholar
• Grus FH, Joachim SC, Wuenschig D, Rieck J, Pfeiffer N. Autoimmunity and glaucoma. J Glaucoma. 2008;17(1):79–84. doi:10.1097/IJG.0b013e318156a592.
   PubMed Web of Science ®Google Scholar
• Lin PW, Chang HW, Lin JP, Lai IC. Analysis of peripapillary retinal nerve fiber layer and inner macular layers by spectral-domain optical coherence tomography for detection of early glaucoma. Int J Ophthalmol. 2018;11(7):1163–1172. doi:10.18240/ijo.2018.07.15. Published 2018 Jul 18.
   PubMed Web of Science ®Google Scholar
• Yang JM, Heo H, Park SW. Relationship between retinal morphological findings and autoantibody profile in primary Sjogren’s syndrome. Jpn J Ophthalmol. 2014;58:359–368. doi:10.1007/s10384-014-0327-3.
   PubMed Web of Science ®Google Scholar
• Yang JM, Sung MS, Ji YS, Heo H, Park SW. Analysis of clinical factors associated with retinal morphological changes in patients with primary Sjogren’s Syndrome. PLoS One. 2016;11:e0157995. doi:10.1371/journal.pone.0157995.
   PubMedGoogle Scholar
• Wax MB, Tezel G, Saito I, et al. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol. 1998;125(2):145–157. doi:10.1016/s0002-9394(99)80084-1.
   PubMed Web of Science ®Google Scholar
• Ho Chan WS. Taiwan’s healthcare report 2010. Epma J. 2010;1(4):563–585. doi:10.1007/s13167-010-0056-8.
   PubMedGoogle Scholar
• Chinese Hospital Association. ICD-9-CM English-Chinese Dictionary. 2000.
   Google Scholar
• Casson RJ. Medical therapy for glaucoma: a review. Clin Exp Ophthalmol. 2022;50(2):198–212. doi:10.1111/ceo.13989.
   PubMed Web of Science ®Google Scholar
• Plummer CE, Bras D, Grozdanic S, et al. Prophylactic anti-glaucoma therapy in dogs with primary glaucoma: a practitioner survey of current medical protocols. Vet Ophthalmol. 2021;24(Suppl 1):96–108. doi:10.1111/vop.12820.
   PubMedGoogle Scholar
• Grant WM, JF B Jr. Why do some people go blind from glaucoma? Ophthalmology. 1982;89(9):991–998. doi:10.1016/s0161-6420(82)34675-8.
   PubMed Web of Science ®Google Scholar
• Coleman AL, Kodjebacheva G. Risk factors for glaucoma needing more attention. Open Ophthalmol J. 2009;3:38–42. doi:10.2174/1874364100903020038. Published 2009 Sep 17.
   PubMedGoogle Scholar
• Rodrigues AR, Soares R. Inflammation in Sjögren’s syndrome: cause or consequence? Autoimmunity. 2017;50(3):141–150. doi:10.1080/08916934.2017.1280027.
   PubMed Web of Science ®Google Scholar
• Hernández-Molina G, Leal-Alegre G, Michel-Peregrina M. The meaning of anti-Ro and anti-La antibodies in primary Sjögren’s syndrome. Autoimmun Rev. 2011;10(3):123–125. doi:10.1016/j.autrev.2010.09.001.
   PubMed Web of Science ®Google Scholar
• Hammam T, Montgomery D, Morris D, Imrie F. Prevalence of serum autoantibodies and paraproteins in patients with glaucoma. Eye (Lond). 2008;22(3):349–353. doi:10.1038/sj.eye.6702613.
   PubMed Web of Science ®Google Scholar
• Wax MB. The case for autoimmunity in glaucoma. Exp Eye Res. 2011;93(2):187–190. doi:10.1016/j.exer.2010.08.016.
   PubMed Web of Science ®Google Scholar
• Wheat JL, Rangaswamy NV, Harwerth RS. Correlating RNFL thickness by OCT with perimetric sensitivity in glaucoma patients. J Glaucoma. 2012;21(2):95–101. doi:10.1097/IJG.0b013e31820bcfbe.
   PubMed Web of Science ®Google Scholar
• Yang Z, Tatham AJ, Weinreb RN, Medeiros FA, Liu T, Zangwill LM. Diagnostic ability of macular ganglion cell inner plexiform layer measurements in glaucoma using swept source and spectral domain optical coherence tomography. PLoS One. 2015;10(5):e0125957. doi:10.1371/journal.pone.0125957. Published 2015 May 15.
   PubMed Web of Science ®Google Scholar
• Soejima K, Nakamura H, Tamai M, Kawakami A, Eguchi K. Activation of MKK4 (SEK1), JNK, and c-Jun in labial salivary infiltrating T cells in patients with Sjögren’s syndrome. Rheumatol Int. 2007;27(4):329–333. doi:10.1007/s00296-006-0229-x.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Kawakami A, Yamasaki S, Kawabe Y, Nakamura T, Eguchi K. Expression of mitogen activated protein kinases in labial salivary glands of patients with Sjögren’s syndrome. Ann Rheum Dis. 1999;58(6):382–385. doi:10.1136/ard.58.6.382.
   PubMed Web of Science ®Google Scholar
• Sahay P, Rao A, Padhy D, et al. Functional activity of matrix metalloproteinases 2 and 9 in tears of patients with glaucoma. Invest Ophthalmol Vis Sci. 2017;58(6):BIO106–113. doi:10.1167/iovs.17-21723.
   PubMed Web of Science ®Google Scholar
• Singh M, Tyagi SC. Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology. Int J Ophthalmol. 2017;10(8):1308–1318. doi:10.18240/ijo.2017.08.20. Published 2017 Aug 18.
   PubMed Web of Science ®Google Scholar
• Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjögren’s syndrome. Nat Rev Rheumatol. 2013;9(9):544–556. doi:10.1038/nrrheum.2013.110.
   PubMed Web of Science ®Google Scholar
• Hulkkonen J, Pertovaara M, Antonen J, et al. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren’s syndrome. Rheumatology (Oxford). 2004;43(12):1476–1479. doi:10.1093/rheumatology/keh369.
   PubMed Web of Science ®Google Scholar
• Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8(3):221–233. doi:10.1038/nrm2125.
   PubMed Web of Science ®Google Scholar
• Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172–180.
   PubMed Web of Science ®Google Scholar
• De Groef L, Van Hove I, Dekeyster E, Stalmans I, Moons L. Mmps in the trabecular meshwork: promising targets for future glaucoma therapies? Invest Ophthalmol Vis Sci. 2013;54(12):7756–7763. doi:10.1167/iovs.13-13088. Published 2013 Nov 21.
   PubMed Web of Science ®Google Scholar
• Schlötzer-Schrehardt U, Lommatzsch J, Küchle M, Konstas AG, Naumann GO. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2003;44(3):1117–1125. doi:10.1167/iovs.02-0365.
   PubMed Web of Science ®Google Scholar
• Prasad D, Poddar U, Kanaujia V, Yachha SK, Srivastava A. Effect of long-term oral steroids on intraocular pressure in children with autoimmune hepatitis: a prospective cohort study. J Glaucoma. 2019;28(10):929–933. doi:10.1097/IJG.0000000000001352.
   PubMed Web of Science ®Google Scholar
• Vavvas D, Huynh N, Pasquale L, Berson EL. Progressive hydroxychloroquine toxicity mimicking low-tension glaucoma after discontinuation of the drug. Acta Ophthalmol. 2010;88(1):156–157. doi:10.1111/j.1755-3768.2008.01359.x.
   PubMed Web of Science ®Google Scholar
• Bai YC, Liu CH, Leong PY, Lai KL, Chen HH, Wei JC. The risk of major adverse cardiovascular events in ankylosing spondylitis patients with a history of acute anterior uveitis: a nationwide, population based cohort study. Front Med (Lausanne). 2022;9:884800. doi:10.3389/fmed.2022.884800. Published 2022 Jul 7
   PubMed Web of Science ®Google Scholar